在患有肥胖症的患者中,丁-梅拉诺科丁路径变异和胃空气
Lizeth Cifuentes1, Wissam Ghusn1, Alejandro Campos1
1Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Neurogastroenterology and motility
|February 16, 2024
概括
瘦素-MC4R路径变异的携带者在肥胖患者中表现出延迟的胃排空 (GE). 这表明,丁-MC4R通路与胃运动调节之间存在显著联系.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 加速胃排空 (GE) 是一种常见的特征,在肥胖个体中观察到.
- 脑下垂体丁-黑色皮质素4受体 (Leptin-MC4R) 途径内的突变经常与肥胖有关.
- 研究莱普-MC4R通路变体与GE之间的联系对于理解肥胖病理生理学至关重要.
研究的目的:
- 调查严重肥胖患者中莱普-MC4R途径变异与胃空化 (GE) 之间的关联.
- 为了比较乐-MC4R路径变异的载体和非载体之间的GE率.
- 分析变体位置 (上游与下游) 对GE的影响.
主要方法:
- 一项涉及95名患有严重肥胖病史的患者的横截面研究.
- 患者的基因型鉴定和使用2小时和4小时的光学图形来评估GE.
- 使用ANCOVA和ANOVA进行统计分析,以比较群体之间的GE百分比,控制体重和性别.
主要成果:
- 这项研究包括9家航空公司和86家非航空公司.
- 与非载体相比,携带乐-MC4R通路变异的人在2小时和4小时内显著延迟了GE (分别为p=0.03和p=0.005).
- 在上游运营商,下游运营商和2小时和4小时的非运营商之间观察到GE的显著差异 (分别为p=0.02和p=0.01).
结论:
- 莱普-MC4R通路中的异合变异与肥胖个体的胃空化延迟有关.
- 这些发现凸显了勒-MC4R通路与胃运动调节之间的显著关系.
- 对莱普-MC4R通路的进一步研究可能为肥胖和相关胃肠道疾病提供新的治疗点.
相关概念视频
01:30Regulation of Food Intake
228
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
228
01:24Glucagon-like Receptor Agonists
322
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
322
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252
01:40Hormonal Regulation
43.5K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.5K
01:24Obesity
501
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
501